ClinicalTrials.govpublic full text
MAGIC Ruxolitinib for aGVHD
acute graft-versus-host disease, allogeneic bone marrow transplantation, adverse effects, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859487
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.